Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypouricemic effect of 2,4-dihydroxybenzoic acid methyl ester in hyperuricemic mice through inhibiting XOD and down-regulating URAT1
Tianqiao Yong, Danling Liang, Chun Xiao, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113303-113303
Open Access | Times Cited: 10

Showing 10 citing articles:

Discovery of digallic acid as XOD/URAT1 dual target inhibitor for the treatment of hyperuricemia
Fengxin Zheng, Suiqing Mai, Xiaolin Cen, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107381-107381
Closed Access | Times Cited: 6
Targeting purine metabolism-related enzymes for therapeutic intervention: A review from molecular mechanism to therapeutic breakthrough
Di Wu, Shengqiang Yang, Chenyang Yuan, et al.
International Journal of Biological Macromolecules (2024), pp. 136828-136828
Closed Access | Times Cited: 6
Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2020–present)
Xiaoyu Shi, Tong Zhao, Edeildo Ferreira da Silva‐Júnior, et al.
Expert Opinion on Therapeutic Patents (2022) Vol. 32, Iss. 12, pp. 1175-1184
Closed Access | Times Cited: 22
Comprehensive overview of different medicinal parts from Morus alba L.: chemical compositions and pharmacological activities
Yumei Wang, Qing Ai, GU Mei-ling, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Comprehensive characterisation of the active ingredients of Smilax glabra Roxb based on chemical fingerprinting, metabolic fingerprinting and pharmacodynamic fingerprinting
Wenqing Shi, Mengqi Jia, Xiao Li, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Discovery of novel benzbromarone analogs with improved pharmacokinetics and benign toxicity profiles as antihyperuricemic agents
Zean Zhao, Jin Liu, L. Yuan, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114682-114682
Closed Access | Times Cited: 11
Study on the Underlying Mechanism of Yinhua Gout Granules in the Treatment of Gouty Arthritis by Integrating Transcriptomics and Network Pharmacology
Qiang-qiang Fan, Bingtao Zhai, Dan Zhang, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 3089-3112
Open Access
Bioassay-Guided Isolation and Identification of Xanthine Oxidase Inhibitory Constituents from the Fruits of Chaenomeles speciosa (Sweet) Nakai
Kui Li, Ruoling Xu, Meng‐Ting Kuang, et al.
Molecules (2024) Vol. 29, Iss. 18, pp. 4468-4468
Open Access
Friedericia chica, a medicinal plant from the Amazon region, is repellent against Aedes aegypti: in vivo and molecular docking evidence
Daniela Miorando, Juliana Cristina Maccagnan, Cristian Alex Dalla Vecchia, et al.
Chemistry & Biodiversity (2024)
Closed Access
Anti-hyperuricemic effects of the seeds of Hovenia acerba in hyperuricemia mice
Ya Wang, Liao Xing-jiang, Jinjuan Zhang, et al.
Journal of Ethnopharmacology (2024) Vol. 340, pp. 119215-119215
Closed Access
Page 1

Scroll to top